EcoDrugPlus

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSDLEG00000003876
Gene Symbol: PSMB3
3 Cross references
251 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSDLEG00000011388
Gene Symbol: PSMB4
3 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Beta 5

Ensembl ID : ENSDLEG00000019970
Gene Symbol: PSMB5
3 Cross references
221 Possible Orthologues:

Proteasome 20s Subunit Beta 6

Ensembl ID : ENSDLEG00000017323
Gene Symbol: PSMB6
3 Cross references
209 Possible Orthologues:

Proteasome 20s Subunit Beta 7

Ensembl ID : ENSDLEG00000000050
Gene Symbol: PSMB7
3 Cross references
217 Possible Orthologues:

Proteasome 20s Subunit Beta 8

Ensembl ID : ENSDLEG00000021995
Gene Symbol: PSMB8
3 Cross references
221 Possible Orthologues:

Proteasome 20s Subunit Beta 9

Ensembl ID : ENSDLEG00000008143
Gene Symbol: PSMB9
3 Cross references
214 Possible Orthologues:

Proteasome 26s Subunit, Atpase 1

Ensembl ID : ENSDLEG00000012654
Gene Symbol: PSMC1
3 Cross references
316 Possible Orthologues:

Proteasome 26s Subunit, Atpase 2

Ensembl ID : ENSDLEG00000004157
Gene Symbol: PSMC2
3 Cross references
228 Possible Orthologues:

Proteasome 26s Subunit, Atpase 3

Ensembl ID : ENSDLEG00000000360
Gene Symbol: PSMC3
3 Cross references
228 Possible Orthologues:

Proteasome 26s Subunit, Atpase 4

Ensembl ID : ENSDLEG00000013437
Gene Symbol: PSMC4
3 Cross references
199 Possible Orthologues:

Proteasome 26s Subunit, Atpase 5

Ensembl ID : ENSDLEG00000006260
Gene Symbol: PSMC5
3 Cross references
226 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).